9.455USD+2.33%Mkt Cap: 879.79M USDP/E: —Last update: 2026-05-26
MeiraGTx Holdings plc, a clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited ret…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap879.79M USD
Enterprise Value894.86M USD
Revenue (TTM)79.76M USD
Gross Profit76.55M USD
Net Income (TTM)-114.20M USD
Revenue/Share0.9850 USD
Last Price9.455 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees409
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINKYG596651029
Valuation
P/E (Trailing)—
P/E (Forward)-6.54
PEG—
EV/EBITDA-9.65
EV/Revenue11.22
P/S11.02
P/B-13.29
EPS (TTM)-1.48
EPS (Forward)-1.45
52W Range
4.81566% of range11.85
52W High11.85 USD
52W Low4.815 USD
Profitability
Gross Margin94.05%
Oper. Margin-13930.72%
EBITDA Margin-116.25%
Profit Margin-140.31%
ROE1971.36%
ROA-46.72%
Growth
Revenue Growth-84.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-46.36M USD
CapEx (TTM)4.24M USD
FCF Margin56.44%
FCF Yield5.12%
Net Debt15.99M USD
Net Debt/EBITDA-0.17
Balance Sheet
Debt/Equity-15.31
Current Ratio0.55
Quick Ratio0.51
Book Value/Sh-0.7140 USD
Cash/Share0.7730 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)28.25 USD
Target Range19.00 USD – 50.00 USD
# Analysts8
Ownership
Shares Out.92.61M
Float52.27M
Insiders17.80%
Institutions60.51%
Short Interest
Short Ratio5.1d
Short % Float8.77%
Short % Out.6.19%
Shares Short5.73M
Short (prev mo.)5.15M
Technical
SMA 509.085 (+4.1%)
SMA 2008.229 (+14.9%)
Beta1.24
S&P 52W Chg28.31%
Avg Vol (30d)941.64K
Avg Vol (10d)830.30K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—